Zehua Wang Selected Research

CRISPR-Associated Protein 9

1/2021

EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zehua Wang Research Topics

Disease

109	Neoplasms (Cancer) 04/2024 - 01/2002
46	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 01/2004
32	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 01/2005
19	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2005
16	Ovarian Epithelial Carcinoma 01/2021 - 04/2003
11	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2006
10	Carcinogenesis 01/2023 - 10/2010
6	Carcinoma (Carcinomatosis) 01/2024 - 03/2010
5	Stomach Neoplasms (Stomach Cancer) 11/2023 - 11/2021
5	Lymphatic Metastasis 09/2022 - 08/2011
5	Infections 01/2020 - 12/2002
4	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 02/2012
3	Inflammation (Inflammations) 01/2023 - 01/2017
3	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 06/2008
3	Uterine Cervical Dysplasia 01/2017 - 01/2005
2	Adenocarcinoma 01/2024 - 04/2003
2	Melanoma (Melanoma, Malignant) 01/2023 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2011
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2017
2	COVID-19 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2017
2	Hemorrhage 01/2020 - 09/2011
2	Disease Progression 02/2019 - 01/2014
2	Pre-Eclampsia (Preeclampsia) 04/2017 - 02/2004
2	Ascites 11/2015 - 01/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2006
19	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2004
14	PlatinumIBA 03/2024 - 07/2005
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2013
11	Messenger RNA (mRNA)IBA 01/2024 - 02/2004
11	MicroRNAs (MicroRNA)IBA 05/2023 - 10/2010
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2005
9	Long Noncoding RNAIBA 12/2023 - 01/2018
8	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2004
7	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 10/2009
5	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 06/2009
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2006
5	EnzymesIBA 01/2022 - 10/2009
5	Enhancer of Zeste Homolog 2 ProteinIBA 06/2018 - 04/2013
4	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2022
4	olaparibIBA 03/2024 - 03/2019
4	Conditioned Culture MediaIBA 01/2024 - 11/2014
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 11/2019
4	Epidermal Growth Factor (EGF)IBA 01/2023 - 01/2020
4	AngiopoietinsIBA 12/2022 - 01/2017
4	Immunoglobulins (Immunoglobulin)IBA 12/2022 - 01/2018
4	Cadherins (E-Cadherin)IBA 10/2021 - 12/2010
4	VimentinIBA 10/2021 - 08/2011
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 03/2019
3	IntegrinsIBA 01/2024 - 01/2023
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 01/2020
3	Angiopoietin-2IBA 12/2022 - 01/2017
3	Carboplatin (JM8)FDA LinkGeneric 08/2022 - 03/2012
3	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2005
3	HeterochromatinIBA 01/2021 - 03/2019
3	CytokinesIBA 01/2020 - 12/2002
3	Voltage-Gated Sodium ChannelsIBA 02/2019 - 02/2009
2	Glutamine (L-Glutamine)FDA Link 04/2024 - 11/2016
2	N-methyladenosineIBA 01/2024 - 01/2023
2	LigandsIBA 01/2024 - 01/2022
2	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 06/2018
2	Estrogens (Estrogen)FDA Link 12/2023 - 10/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 12/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 10/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023 - 12/2022
2	Angiopoietin-1IBA 12/2022 - 01/2017
2	Therapeutic UsesIBA 02/2021 - 12/2020
2	Estrogen ReceptorsIBA 10/2020 - 09/2013
2	TOR Serine-Threonine KinasesIBA 10/2020 - 06/2008
2	Histones (Histone)IBA 01/2020 - 10/2010
2	ImmunosorbentsIBA 01/2017 - 10/2009
2	Androgen Receptors (Androgen Receptor)IBA 11/2016 - 02/2012
2	Lysine (L-Lysine)FDA Link 11/2016 - 10/2010
2	MethyltransferasesIBA 01/2016 - 10/2010
2	CateninsIBA 04/2014 - 08/2011
2	Histone MethyltransferasesIBA 03/2014 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2013 - 01/2013
2	UbiquitinIBA 09/2013 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012 - 10/2010
2	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2011 - 06/2009
2	CollagenIBA 06/2009 - 01/2006
2	Caspase 3 (Caspase-3)IBA 01/2006 - 01/2005
2	SurvivinIBA 07/2005 - 01/2005
2	cloricromen (AD 6)IBA 03/2005 - 01/2004
1	Circulating Tumor DNAIBA 03/2024
1	integrin alpha7beta1IBA 01/2024

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2024 - 04/2003
24	Therapeutics 11/2023 - 02/2012
14	Immunotherapy 03/2024 - 01/2021
12	Hysterectomy 01/2023 - 06/2010
9	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 04/2003
7	Neoadjuvant Therapy 03/2024 - 07/2012
5	Radiotherapy 08/2022 - 03/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2023 - 01/2022
2	Intraperitoneal Injections 05/2023 - 09/2015
2	Gastrectomy 01/2023 - 01/2022
2	Aftercare (After-Treatment) 03/2012 - 01/2006
1	Knee Replacement Arthroplasty (Total Knee Replacement) 02/2024